Impressive Response to Dose-Dense Chemotherapy in a Patient with NUT Midline Carcinoma.

about

NUT midline carcinoma mimicking a germ cell tumor: a case report NUT carcinoma in children and adults: A multicenter retrospective study.A Clinical Trial Using Attrition Combined with 5-Aminolevulinic Acids Based Photodynamic Therapy in Treating Squamous Cell Carcinoma.

P2860

Q36195509-BB4D41B6-E90A-438C-8033-2291DF882C1E Q39393379-E125614B-4FB4-4ED5-BA39-BCC0E523EC92 Q42372360-E0118EC1-0E38-402E-A305-44F6371A75F5

P2860

Impressive Response to Dose-Dense Chemotherapy in a Patient with NUT Midline Carcinoma.

Item

http://www.wikidata.org/entity/Q35821531

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Impressive Response to Dose-Dense Chemotherapy in a Patient with NUT Midline Carcinoma.

@ast

Impressive Response to Dose-Dense Chemotherapy in a Patient with NUT Midline Carcinoma.

@en

type

Item

label

Impressive Response to Dose-Dense Chemotherapy in a Patient with NUT Midline Carcinoma.

@ast

Impressive Response to Dose-Dense Chemotherapy in a Patient with NUT Midline Carcinoma.

@en

prefLabel

Impressive Response to Dose-Dense Chemotherapy in a Patient with NUT Midline Carcinoma.

@ast

Impressive Response to Dose-Dense Chemotherapy in a Patient with NUT Midline Carcinoma.

@en

P1476

Impressive Response to Dose-Dense Chemotherapy in a Patient with NUT Midline Carcinoma

@en

P2093

Annalisa Fontana

http://www.w3.org/2001/XMLSchema#string

Michela Maur

http://www.w3.org/2001/XMLSchema#string

Paolo Corradini

http://www.w3.org/2001/XMLSchema#string

P2860

Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains

BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma

Demystified molecular pathology of NUT midline carcinomas

Clinicopathologic features and long-term outcomes of NUT midline carcinoma.

A review of NUT midline carcinoma.

Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody.

NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism.

Differentiation of NUT midline carcinoma by epigenomic reprogramming.

Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy.

Mechanistic analysis of the role of bromodomain-containing protein 4 (BRD4) in BRD4-NUT oncoprotein-induced transcriptional activation.

P304

424-429

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12659/AJCR.893879

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280030362

http://www.w3.org/2001/XMLSchema#string

P698

26140332

http://www.w3.org/2001/XMLSchema#string

P921

chemotherapy

P932

4492486

http://www.w3.org/2001/XMLSchema#string

Impressive Response to Dose-Dense Chemotherapy in a Patient with NUT Midline Carcinoma.

about

P2860

P2860

Impressive Response to Dose-Dense Chemotherapy in a Patient with NUT Midline Carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P921

P932